JP2003510292A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003510292A5 JP2003510292A5 JP2001526202A JP2001526202A JP2003510292A5 JP 2003510292 A5 JP2003510292 A5 JP 2003510292A5 JP 2001526202 A JP2001526202 A JP 2001526202A JP 2001526202 A JP2001526202 A JP 2001526202A JP 2003510292 A5 JP2003510292 A5 JP 2003510292A5
- Authority
- JP
- Japan
- Prior art keywords
- dtpa
- vaccine
- tetanus
- detoxified
- toxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960005486 vaccine Drugs 0.000 description 13
- 239000000427 antigen Substances 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 7
- 201000005702 Pertussis Diseases 0.000 description 6
- 206010043376 Tetanus Diseases 0.000 description 5
- 206010013023 diphtheria Diseases 0.000 description 5
- 108010049048 Cholera Toxin Proteins 0.000 description 4
- 102000009016 Cholera Toxin Human genes 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 239000003814 drug Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 108010071134 CRM197 (non-toxic variant of diphtheria toxin) Proteins 0.000 description 1
- 108010081690 Pertussis Toxin Proteins 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229930186900 holotoxin Natural products 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 108010021711 pertactin Proteins 0.000 description 1
- 229960000814 tetanus toxoid Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9923060.9A GB9923060D0 (en) | 1999-09-29 | 1999-09-29 | Vaccine |
| GB9923060.9 | 1999-09-29 | ||
| PCT/IB2000/001440 WO2001022993A2 (en) | 1999-09-29 | 2000-09-28 | MUCOSAL DTPa VACCINES |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012000806A Division JP2012067137A (ja) | 1999-09-29 | 2012-01-05 | 粘膜ＤＴＰａワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003510292A JP2003510292A (ja) | 2003-03-18 |
| JP2003510292A5 true JP2003510292A5 (https=) | 2007-11-15 |
| JP5025867B2 JP5025867B2 (ja) | 2012-09-12 |
Family
ID=10861826
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001526202A Expired - Fee Related JP5025867B2 (ja) | 1999-09-29 | 2000-09-28 | 粘膜ＤＴＰａワクチン |
| JP2012000806A Withdrawn JP2012067137A (ja) | 1999-09-29 | 2012-01-05 | 粘膜ＤＴＰａワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012000806A Withdrawn JP2012067137A (ja) | 1999-09-29 | 2012-01-05 | 粘膜ＤＴＰａワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7279169B1 (https=) |
| EP (1) | EP1223975B1 (https=) |
| JP (2) | JP5025867B2 (https=) |
| AT (1) | ATE431744T1 (https=) |
| CA (1) | CA2386023C (https=) |
| CY (1) | CY1110327T1 (https=) |
| DE (1) | DE60042243D1 (https=) |
| DK (1) | DK1223975T3 (https=) |
| ES (1) | ES2323936T3 (https=) |
| GB (1) | GB9923060D0 (https=) |
| PT (1) | PT1223975E (https=) |
| WO (1) | WO2001022993A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9326174D0 (en) * | 1993-12-22 | 1994-02-23 | Biocine Sclavo | Mucosal adjuvant |
| CA2434546C (en) | 2001-01-12 | 2012-09-11 | Chiron Corporation | Induction of immune response by a replication-defective venezuelan equine encephalitis-sindbis chimeric virus replicon particle encoding an antigen |
| GB0302218D0 (en) | 2003-01-30 | 2003-03-05 | Chiron Sri | Vaccine formulation & Mucosal delivery |
| NZ536859A (en) * | 2002-05-14 | 2007-11-30 | Chiron Srl | Mucosal combination vaccines for bacterial meningitis |
| US8425922B2 (en) | 2009-01-05 | 2013-04-23 | EpitoGenesis, Inc. | Adjuvant compositions and methods of use |
| TW201103980A (en) * | 2009-07-08 | 2011-02-01 | Abbott Biologicals Bv | Viral vaccine and use thereof |
| US10561720B2 (en) | 2011-06-24 | 2020-02-18 | EpitoGenesis, Inc. | Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators |
| BR112014014950B1 (pt) * | 2011-12-21 | 2022-03-29 | Bionet-Asia, Co. Ltd | Cepa de bordetella pertussis geneticamente modificada, e, métodos para produzir uma cepa de bordetella pertussis modificada e para produzir antígenos de bordetella pertussis |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2849632B2 (ja) | 1988-04-08 | 1999-01-20 | 社団法人北里研究所 | ワクチン製剤 |
| IT1248735B (it) * | 1990-06-21 | 1995-01-26 | Sclavo Spa | Vaccini acellulari contro la pertosse |
| IT1253009B (it) | 1991-12-31 | 1995-07-10 | Sclavo Ricerca S R L | Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini |
| GB9513371D0 (en) | 1995-06-30 | 1995-09-06 | Biocine Spa | Immunogenic detoxified mutant toxins |
| GB9209118D0 (en) | 1992-04-28 | 1992-06-10 | Sb 120 Amsterdam Bv | Vaccine compositions |
| SG48365A1 (en) | 1992-05-23 | 1998-04-17 | Smithkline Beecham Biolog | Combined vaccines comprising hepatitis b surface antigen and other antigens |
| ATE280235T1 (de) * | 1993-03-05 | 2004-11-15 | Wyeth Corp | Plasmid zur herstellung von crm-protein und diphtherie-toxin |
| JP3752264B2 (ja) * | 1995-02-24 | 2006-03-08 | 財団法人化学及血清療法研究所 | 混合ワクチン |
| GB9622133D0 (en) | 1996-10-24 | 1996-12-18 | Niotech Limited | Inverter circuits |
| US5980898A (en) * | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
| US7115730B1 (en) * | 1999-04-27 | 2006-10-03 | Chiron Srl | Immunogenic detoxified mutant E. coli LT-A-toxin |
-
1999
- 1999-09-29 GB GBGB9923060.9A patent/GB9923060D0/en not_active Ceased
-
2000
- 2000-09-28 PT PT00962770T patent/PT1223975E/pt unknown
- 2000-09-28 ES ES00962770T patent/ES2323936T3/es not_active Expired - Lifetime
- 2000-09-28 DK DK00962770T patent/DK1223975T3/da active
- 2000-09-28 CA CA2386023A patent/CA2386023C/en not_active Expired - Fee Related
- 2000-09-28 AT AT00962770T patent/ATE431744T1/de active
- 2000-09-28 US US10/089,367 patent/US7279169B1/en not_active Expired - Fee Related
- 2000-09-28 EP EP00962770A patent/EP1223975B1/en not_active Expired - Lifetime
- 2000-09-28 DE DE60042243T patent/DE60042243D1/de not_active Expired - Lifetime
- 2000-09-28 JP JP2001526202A patent/JP5025867B2/ja not_active Expired - Fee Related
- 2000-09-28 WO PCT/IB2000/001440 patent/WO2001022993A2/en not_active Ceased
-
2009
- 2009-08-12 CY CY20091100868T patent/CY1110327T1/el unknown
-
2012
- 2012-01-05 JP JP2012000806A patent/JP2012067137A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4870895B2 (ja) | ワクチン組成物 | |
| RU2378008C2 (ru) | Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку | |
| JP2005526847A5 (https=) | ||
| JP2004501873A5 (https=) | ||
| Isaka et al. | Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant | |
| JP2002502882A5 (https=) | ||
| EP1005367A2 (en) | Vaccines containing bordetella pertussis antigen | |
| ES2141765T3 (es) | Composiciones de vacuna de administracion por la mucosa. | |
| RU2004136299A (ru) | Мукозальные вакцины с хитозановым адъювантом и/или антигенами менингококков | |
| NZ598367A (en) | Multiple vaccination including serogroup C meningococcus | |
| JP2003510292A5 (https=) | ||
| CY1110327T1 (el) | DTPa ΕΜΒΟΛΙΑ ΒΛΕΝΝΟΓΟΝΟΥ | |
| ATE182270T1 (de) | Mukosale verabreichung von pneumokokken-antigenen | |
| CN101559223A (zh) | 流脑白百破联合疫苗 | |
| JP2003514030A5 (https=) | ||
| CA2388054A1 (en) | Compositions and methods for stimulating an immune response against infectious agents | |
| Bae et al. | Quadrivalent combined vaccine, including diphtheria toxoid, tetanus toxoid, detoxified whole cell pertussis, and hepatitis B surface antigen | |
| Moingeon | Challenges and Opportunities in the Development of New Conjugate Vaccines against Infectious Diseases |